Portfolio company
Apollo Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops new medicines based on medical research for patients with various therapeutic needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sequel Therapeutics
This pharmaceutical company develops and acquires medicines for patients in specific therapeutic areas.
IntrepidiaBio
This biopharmaceutical company develops therapeutic products to address unmet medical needs for patients.
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
Odyssey Therapeutics
This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.
Nilo Therapeuti
This biotechnology company develops medicines that target neural circuits to treat patients with autoimmune and inflammatory diseases.
Spero
This biopharmaceutical company develops medicines for immune-mediated diseases and multi-drug resistant bacterial infections for patients with unmet medical needs.
Allorion Therapeutics
This biopharmaceutical company develops small-molecule therapies for cancer and autoimmune diseases to serve patients and global pharmaceutical partners.
Aiolos Bio
This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.
